Fecal Microbiota in Premature Infants Prior to Necrotizing Enterocolitis

By the time a premature infant shows the first clinical signs of necrotizing enterocolitis, the bacteria in their gut look almost identical to those in a healthy infant's gut. There are no warning signals and no obvious culprits. However, if we go back one week, before any symptoms appeared, the picture is completely different. That temporal gap is what Mai and colleagues went looking for, and what they found reframes how we think about one of the most lethal diseases in neonatal medicine. Necrotizing enterocolitis, or NEC, is a devastating intestinal disease affecting the most vulnerable infants: those born at or before 32 weeks of gestation or weighing 1,250 grams or less at birth. It typically strikes in the second week of life, right around the time anaerobic bacteria are establishing themselves in the gut. The burden of mortality and morbidity is severe. Yet, for decades, clinicians have struggled to reliably predict which infants will develop it. The leading hypothesis is called the abnormal colonization hypothesis, which suggests that an aberrant pattern of bacterial colonization in the neonatal gut does not just accompany NEC but actually causes it. The evidence supporting this idea is suggestive. NEC has never been observed in germ-free animals, indicating that bacteria are necessary for the disease to occur. Infants with NEC often show bacteremia and endotoxemia, signs that bacteria or their products have crossed the gut wall. While individual centers have identified clusters of NEC tied to specific organisms, no single pathogen has been consistently implicated across different sites. This points toward community-level disruption rather than one bad actor. For a long time, the missing piece was the tool necessary to characterize these communities. Culture-based microbiology misses a substantial fraction of gut bacteria and tells us almost nothing about community structure. What changed this was high-throughput 16S ribosomal RNA sequencing. This method reads a universal bacterial gene, essentially a barcode present in all bacteria, allowing for the identification of organisms that could never grow in a dish. Mai and colleagues used this approach and, after filtering out short and low-quality reads, retained a total of 110,021 sequences for analysis. That scale of data was simply not possible a decade earlier. The study design was longitudinal and prospective. Infants were enrolled from three University of Florida-affiliated hospitals and followed from their very first stool through discharge, with weekly samples collected and frozen. From roughly 200 enrolled babies, nine developed NEC, confirmed at Bell Stage 2 or 3, the diagnostic criteria used to distinguish true NEC from milder intestinal disturbances. Each infant with NEC was matched one-to-one with a control infant based on gestational age, birth weight, birth center, date of birth within two months, and predominant feeding type. For each pair, the team selected two samples: one collected within 72 hours of NEC diagnosis, and one collected about a week before — with a median of seven days, ranging from three to ten. Sequences were binned into operational taxonomic units, or OTUs, essentially bacterial fingerprints defined by how similar their genetic barcodes are. After filtering singletons and rare OTUs, the team had 2,636 OTUs at the finest resolution level for analysis. Diversity was calculated using Chao1 rarefaction curves, and community structure was visualized using UniFrac distances, which measure how phylogenetically distinct two microbial communities are from each other. Here is what they found. At the time point of less than 72 hours, the microbiota of NEC cases and controls looked essentially the same. Standard diversity indices, OTU counts, and community structure showed no significant differences. If someone was only looking at the moment of diagnosis, they would see nothing remarkable. But step back one week, and the signal emerges clearly. In a principal component analysis based on UniFrac distances, seven of nine control samples clustered tightly together, while the nine NEC cases were scattered — their communities were more heterogeneous and less organized. At the phylum level, the shift is dramatic: NEC cases showed a 34 percent increase in Proteobacteria and a 32 percent decrease in Firmicutes between the one-week sample and the less-than-72-hour sample. Those two numbers are the center of this paper. To put that into context: Firmicutes is the phylum that normally dominates the healthy gut, associated with commensals and less immunogenic bacteria. Proteobacteria is the phylum that includes many gram-negative pathogens and enteric opportunists. A 34 percent bloom of Proteobacteria, paired with a 32 percent collapse of Firmicutes, is not a subtle signal; it's a dramatic restructuring of the microbial community. This occurred only in the NEC group. The matched controls showed no significant change in the proportions of the four dominant phyla: Firmicutes, Proteobacteria, Bacteroidetes, and Actinobacteria — over that same interval. The implication is striking. The preterm gut is sounding an alarm a full week before the infant shows any clinical signs of disease. That window could, in principle, be actionable. Now let’s shift from community patterns down to a single organism, and the findings get even more interesting. The team identified specific OTUs that were elevated in NEC cases at both time points. One stands out. A sequence matching most closely to gamma-Proteobacteria — and more specifically, to the Enterobacteriaceae family, which includes E. coli and Klebsiella — was detected in three of nine NEC infants and in none of the nine matched controls. That difference was significant, with a p-value below 0.01. What made this OTU unusual was what happened when the researchers ran it through GenBank, the global DNA sequence database. No known bacterial strain matched it by more than 97 percent sequence identity. That 97 percent threshold matters: it's the conventional cutoff for bacterial species identification in 16S analysis. Failing to exceed it means this sequence might represent an organism that simply isn't in the reference library — potentially something novel. The sequence grouped closest to Klebsiella in phylogenetic trees, but it wasn't Klebsiella. It was something related, but uncharacterized. The sequencing depth here is relevant. The team averaged over 3,000 sequences per sample, with some samples exceeding 5,600 — more than twenty times deeper than some prior work in this area. That depth allows detection of rare OTUs that would otherwise be buried in noise. The authors are measured about what to make of all this. The study is exploratory. They analyzed more than a thousand OTUs and, while they applied a significance threshold of a p-value below 0.01, they did not correct for multiple comparisons. Nine cases and nine controls represent a small cohort, all drawn from Florida hospitals, so generalizability is genuinely limited. Some of these findings may reflect chance. The authors acknowledge this, stressing that these are signals that demand confirmation, not conclusions that stand alone. That being said, when taken together, the findings draw a coherent picture. One week before NEC, the gut microbiome of affected infants undergoes a measurable community shift: Proteobacteria bloom, Firmicutes recede, and specific uncharacterized organisms appear that are absent in healthy controls. Within 72 hours of diagnosis, the community looks superficially normal again by standard metrics — perhaps because by that point, the damage is already underway through a different mechanism or the bloom has passed its peak. The practical implications follow from the biology. If the microbiome shifts seven days before clinical disease, stool bacterial community profiles could potentially serve as early warning indicators in the neonatal intensive care unit. This would be a diagnostic signal captured before an infant deteriorates. If Proteobacteria blooms and Firmicutes loss are part of the causal pathway, then strategies designed to maintain Firmicutes dominance, such as targeted probiotics, deserve serious investigation. The possible novel pathogen finding opens a different thread. If an uncharacterized Enterobacteriaceae-related organism is consistently present in NEC cases and absent in controls, identifying it fully and understanding how it interacts with the preterm gut becomes a priority. Mai and colleagues present this as a hypothesis to pursue, not a conclusion to act on. But the question it leaves open is the right one: in the guts of the smallest, most vulnerable patients, something unfamiliar may be lurking — and we may now have the tools to find it before it does its damage. This lecture was created by ennepō. Go to https://ennepo.ai to Discover, Create and Follow the latest research in your field. Read when you can. Listen when you want to.